Celebrating Our Visionary Founders
Many of our “founding physicians” met for dinner this past weekend, including Albert Vaiser, MD, and William Hutton, MD, who along with William Snyder, MD, established Texas Retina Associates more than 50 years
read more
Dr. Abbey Taught a Course at the American Academy of Ophthalmology 2023 Annual Meeting
On November 6, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a continuing medical education (CME) course titled, “Secondary IOL Techniques for Retinal Specialists,” at AAO 2023, the annual meeting of the
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including
read more
Dr. Kothari to Speak at Retina World Congress Young Retina Connect Event
On October 29, 2023, Texas Retina Associates’ Nikisha Kothari, MD, will serve as one of seven panelists for Retina World Congress’ (RWC) “Young Retina Connect,” a virtual, interactive event involving retina specialists
read more
Getting to Know Diana Laura, MD
Board-certified ophthalmologist and retina specialist Diana M. Laura, MD, joined Texas Retina Associates in September 2022, and cares for patients in our Dallas Main, Rockwall and Wichita Falls offices. She completed her
read more
Dr. Abbey Publishes Case Report on Macular Hole Closure with Intravitreal Dexamethasone Implant
In the September 2023 issue of the peer-reviewed medical journal Ophthalmic Surgery, Lasers and Imaging Retina, Texas Retina’s Ashkan Abbey, MD, describes the use of a dexamethasone intravitreal implant to close a
read more
New Clinical Trials Available at Texas Retina
Our physicians remain committed to participating in ongoing retina research, providing our patients with access to promising new treatments through clinical trials. In fact, our research program has grown to become one
read more Dr. Abbey Publishes Research on Effectiveness of a Long-acting Injectable Steroid for Patients with Cystoid Macular Edema After Vitrectomy
Long-acting injectable steroids have emerged as a new way to treat chronic intraocular inflammation and cystoid macular edema (CME) that reduces the treatment frequency and burden for retina patients. Texas Retina’s Ashkan
read more
Inflammatory Eye Disease Awareness Week
Prevent Blindness has declared September 18 – 24, 2023, as Inflammatory Eye Disease Awareness Week. There are a number of inflammatory eye conditions. The one we specialize in at Texas Retina Associates
read more Dr. Abbey Presented at the American Society of Retina Specialists 2023 Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, recently presented at the 41st Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) held in Seattle. ASRS is the largest organization of
read more